The program will offer one dose of the 13-valent pneumococcal conjugate vaccine (PCV13) and one dose of the 23-valent pneumococcal polysaccharide vaccine (PPV23). PCV13, a safe 13-serotype inactivated ...
Widespread use of PCV13, which covers additional serotypes 3, 6A and 19A, may contribute to reduce the clonal spread of drug-resistant 19A pneumococci. The author has no relevant affiliations or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback